2010
DOI: 10.1016/j.jdiacomp.2009.11.002
|View full text |Cite
|
Sign up to set email alerts
|

The heteroplasmic m.14709T>C mutation in the tRNAGlu gene in two Tunisian families with mitochondrial diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
9
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
5
3
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 32 publications
(12 citation statements)
references
References 33 publications
3
9
0
Order By: Relevance
“…In fact, the m.3243A4G mutation was described associated with hypertrophic cardiomyopathy (Ito et al, 1992;Majamaa-Voltti et al, 2002), and with dilated cardiomyopathy (Tsujita et al, 2008;Vilarinho et al, 1997). In this study, the m.3243A4G is described in the first time associated to dilated cardiomyopathy in Tunisian population when it was previously described only in 1.07% in Tunisian diabetic population (Bouhaha et al, 2010) but it was absent in Tunisian patients with several mitochondrial diseases (Mezghani et al, 2010;Mkaouar-Rebai et al, 2007). The m.3243A4G mutation was detected with high heteroplasmic rate (63.64%) in the blood leucocytes of the studied patient, and it could probably be detected with a higher level in the myocardium.…”
Section: Discussionsupporting
confidence: 49%
“…In fact, the m.3243A4G mutation was described associated with hypertrophic cardiomyopathy (Ito et al, 1992;Majamaa-Voltti et al, 2002), and with dilated cardiomyopathy (Tsujita et al, 2008;Vilarinho et al, 1997). In this study, the m.3243A4G is described in the first time associated to dilated cardiomyopathy in Tunisian population when it was previously described only in 1.07% in Tunisian diabetic population (Bouhaha et al, 2010) but it was absent in Tunisian patients with several mitochondrial diseases (Mezghani et al, 2010;Mkaouar-Rebai et al, 2007). The m.3243A4G mutation was detected with high heteroplasmic rate (63.64%) in the blood leucocytes of the studied patient, and it could probably be detected with a higher level in the myocardium.…”
Section: Discussionsupporting
confidence: 49%
“…It was indicated that mutations in mtDNA may be associated with obesity. For instance, the tRNA Thr mutation m.10003T>C, as well as the tRNA Glu mutations m.14709T>C, and m.14692A>G have been associated with such disease [6][7][8].…”
Section: Introductionmentioning
confidence: 99%
“…Mitochondria play an imperative role in glucose metabolism, insulin secretion and biogenesis, hence its dysfunction is reportedly found to play a crucial role in diabetes development (Gerbitz et al 1996;Choo Kang et al 2002). Earlier reports showed the association of mitochondrial DNA mutations like 1310C [T, 1382A[C, 1438G[A, 1201A[G, 3243A[G, 3252A[G, 3256A[T, 3264A[C, 3271A[C, 3290T[C, 3303C[T, 3316G[A, 3394T[C, 8296A[G, 8344A[G, 11778G[A, 12026A[G, 12258C[A, 14577T[C, 14709T[C and 16189T[C (Giles et al 1980Alcolado et al 1994;Kalinin et al 1995;Seneca et al 1998;Chinnery et al 2000;Hattori et al 2003;Pranoto 2005;Brandon et al 2005;Liu et al 2007;Mezghani et al 2010;Vijaya Padma et al 2010;Duraisamy et al 2010;Weng et al, 2013) with T2D development. Particularly, mutation in tRNA Leu gene at 3243 (A[G) position and in the subunits of NADH dehydrogenase 1 and 4 have been reported to have strong association with diabetes incidence in different populations (Kalinin et al 1995;Zhao and Zhang 2001;Lam et al 2001;Pranoto 2005;Yu et al 2004;Duraisamy et al 2010;Vijaya Padma et al 2010).…”
Section: Discussionmentioning
confidence: 99%